Authors:
TOUGOU K
NAKAMURA A
WATANABE S
OKUYAMA Y
MORINO A
Citation: K. Tougou et al., PARAOXONASE HAS A MAJOR ROLE IN THE HYDROLYSIS OF PRULIFLOXACIN (NM441), A PRODRUG OF A NEW ANTIBACTERIAL AGENT, Drug metabolism and disposition, 26(4), 1998, pp. 355-359
Citation: A. Morino et al., (E)-2-(4'-METHYL-3'-PENTENYLIDENE)-4-BUTANOLIDE, NAMED BETA-ACARIOLIDE - A NEW MONOTERPENE LACTONE FROM THE MOLD MITE, TYROPHAGUS-PUTRESCENTIAE (ACARINA, ACARIDAE), Bioscience, biotechnology, and biochemistry, 61(11), 1997, pp. 1906-1908
Authors:
NAKAMURA A
HIROTA T
MORINO A
SHIMADA T
UEMATSU T
Citation: A. Nakamura et al., N-OXIDATION OF IRSOGLADINE BY THE CYP2C SUBFAMILY IN THE RAT, DOG, MONKEY AND MAN, Xenobiotica, 27(10), 1997, pp. 995-1003
Citation: Y. Okuyama et al., PHARMACOKINETICS OF PRULIFLOXACIN .1. ABSORPTION, DISTRIBUTION AND EXCRETION IN RATS, DOGS AND MONKEYS AFTER A SINGLE ADMINISTRATION, Arzneimittel-Forschung, 47(3), 1997, pp. 276-284
Citation: Y. Okuyama et al., PHARMACOKINETICS OF PRULIFLOXACIN .2. PHARMACOKINETICS AND EFFECT ON HEPATIC DRUG-METABOLIZING ENZYME-ACTIVITIES AFTER REPEATED ADMINISTRATION AND TRANSFER INTO FETUS AND MILK AFTER A SINGLE ADMINISTRATION IN RATS, Arzneimittel-Forschung, 47(3), 1997, pp. 285-292
Citation: Y. Okuyama et A. Morino, PHARMACOKINETICS OF PRULIFLOXACIN .3. METABOLISM IN RATS, DOGS AND MONKEYS, Arzneimittel-Forschung, 47(3), 1997, pp. 293-298
Authors:
NAKAMURA A
SUGIHARA K
HIROTA T
MORINO A
EZUMI Y
TAKAICHI M
Citation: A. Nakamura et al., PHARMACOKINETICS OF (+ -)-4-DIETHYLAMINO-1,1-DIMETHYLBUT-2-YN-1-YL 2-CYCLOHEXYL-2-HYDROXY-2-PHENYLACETATE MONOHYDROCHLORIDE MONOHYDRATE - 1ST COMMUNICATION - ABSORPTION, DISTRIBUTION AND EXCRETION AFTER SINGLEADMINISTRATION OF C-14-LABELED COMPOUND TO RATS AND DOGS/, Arzneimittel-Forschung, 47(2), 1997, pp. 151-159
Authors:
NAKAMURA A
HIROTA T
SUGIHARA K
WATANABE S
TOUGOU K
MORINO A
EZUMI Y
TAKAICHI M
Citation: A. Nakamura et al., PHARMACOKINETICS OF (+ -)-4-DIETHYLAMINO-1,1-DIMETHYLBUT-2-YN-1-YL 2-CYCLOHEXYL-2-HYDROXY-2-PHENYLACETATE MONOHYDROCHLORIDE MONOHYDRATE - 2ND COMMUNICATION - TISSUE-LEVELS AND ENZYME-ACTIVITY IN RATS AFTER REPEATED ADMINISTRATION, AND PLACENTAL AND MILK TRANSFER AFTER SINGLE ADMINISTRATION/, Arzneimittel-Forschung, 47(2), 1997, pp. 160-168
Citation: A. Nakamura et al., PHARMACOKINETICS OF (+ -)-4-DIETHYLAMINO-1,1-DIMETHYLBUT-2-YN-1-YL 2-CYCLOHEXYL-2-HYDROXY-2-PHENYLACETATE MONOHYDROCHLORIDE MONOHYDRATE - 3RD COMMUNICATION - PLASMA-CONCENTRATIONS OF THE UNCHANGED DRUG AND ITSDEETHYLATED METABOLITE IN RATS, DOGS AND MONKEYS/, Arzneimittel-Forschung, 47(2), 1997, pp. 169-174
Citation: T. Hirota et al., PHARMACOKINETICS OF (+ -)-4-DIETHYLAMINO-1,1-DIMETHYLBUT-2-YN-1-YL 2-CYCLOHEXYL-2-HYDROXY-2-PHENYLACETATE MONOHYDROCHLORIDE MONOHYDRATE 4THCOMMUNICATION - METABOLISM IN RATS AND DOGS/, Arzneimittel-Forschung, 47(2), 1997, pp. 175-181
Citation: T. Sugimoto et al., PHARMACOKINETICS OF THE NEW THYROTROPIN-RELEASING-HORMONE ANALOG MONTIRELIN HYDRATE - 1ST COMMUNICATION - PLASMA-CONCENTRATIONS METABOLISM AND EXCRETION AFTER A SINGLE INTRAVENOUS ADMINISTRATION TO RATS, DOGS AND MONKEYS, Arzneimittel-Forschung, 46(2), 1996, pp. 106-113
Citation: T. Sugimoto et al., PHARMACOKINETICS OF THE NEW THYROTROPIN-RELEASING-HORMONE ANALOG MONTIRELIN HYDRATE - 2ND COMMUNICATION - DISTRIBUTION AND TRANSFER INTO THE FETUS AND MILK AFTER A SINGLE INTRAVENOUS ADMINISTRATION, AND PHARMACOKINETICS AND ENZYME-INDUCTION AFTER REPEATED INTRAVENOUS ADMINISTRATION TO RATS, Arzneimittel-Forschung, 46(2), 1996, pp. 114-127
Citation: T. Sugimoto et al., PHARMACOKINETICS OF THE NEW THYROTROPIN-RELEASING-HORMONE ANALOG MONTIRELIN HYDRATE - 3RD COMMUNICATION - IDENTIFICATION OF METABOLITES IN RAT URINE, Arzneimittel-Forschung, 46(2), 1996, pp. 127-133
Authors:
ITOH Y
SUGIMOTO T
UKAI Y
MORINO A
KIMURA K
Citation: Y. Itoh et al., PERMEABILITY OF NS-3, A THYROTROPIN-RELEASING-HORMONE ANALOG, INTO THE BRAIN AFTER ITS SYSTEMIC ADMINISTRATION IN RATS - A MICRODIALYSIS STUDY, Journal of Pharmacy and Pharmacology, 47(10), 1995, pp. 833-836
Authors:
NAKASHIMA M
UEMATSU T
KOSUGE K
OKUYAMA Y
MORINO A
OZAKI M
TAKEBE Y
Citation: M. Nakashima et al., PHARMACOKINETICS AND SAFETY OF NM441, A NEW QUINOLONE, IN HEALTHY MALE-VOLUNTEERS, Journal of clinical pharmacology, 34(9), 1994, pp. 930-937
Citation: S. Watanabe et al., UTILIZATION OF INTRAVENOUSLY INFUSED MALTOOLIGOSACCHARIDES IN RABBITS, Biological & pharmaceutical bulletin, 16(10), 1993, pp. 1044-1045